Secondary Prophylaxis of Hepatic Encephalopathy: An Open Label Randomized Controlled Trial of Lactulose Versus Placebo

被引:0
|
作者
Sharma, Praveen [1 ]
Sharma, Barjesh [2 ]
Agarwal, Amit [2 ]
Sarin, Shiv [1 ]
机构
[1] ILBS, New Delhi, India
[2] GB Pant Hosp, New Delhi, India
来源
关键词
D O I
10.14309/00000434-200910003-00398
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
398
引用
收藏
页码:S149 / S149
页数:1
相关论文
共 50 条
  • [31] Lactulose Is Highly Potential in Prophylaxis of Hepatic Encephalopathy in Patients with Cirrhosis and Upper Gastrointestinal Bleeding: Results of a Controlled Randomized Trial
    Wen, Jing
    Liu, Qingsen
    Song, Jie
    Tong, Muhong
    Peng, Lihua
    Liang, Hao
    DIGESTION, 2013, 87 (02) : 132 - 138
  • [32] Efficacy and safety of L-ornithine-L-aspartate (LOLA) administration. Open label randomized controlled trial versus lactulose in cirrhotic patients with hyperammonemic hepatic encephalopathy
    Poo, J. L.
    Gongora, J.
    Sanchez-Avila, J. F.
    Aguilar-Castillo, S.
    Garcia Ramos, G.
    Fernandez-Zertuche, M.
    Rodriguez-Fragoso, L.
    Uribe, M.
    JOURNAL OF HEPATOLOGY, 2007, 46 : S36 - S36
  • [33] A randomized control trial of lactulose versus probiotics versus lactulose plus probiotics in the treatment of minimal hepatic encephalopathy of cirrhosis
    Sharma, Praveen
    Sharma, B. C.
    Puri, Vinod
    Sarin, S. K.
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2006, 101 (09): : S178 - S178
  • [34] RIFAXIMIN ALONE VERSUS COMBINATION WITH NORFLOXACIN FOR SECONDARY PROPHYLAXIS OF SPONTANEOUS BACTERIAL PERITONITIS WITH HEPATIC ENCEPHALOPATHY: A RANDOMIZED-CONTROLLED TRIAL
    Gupta, Tarana
    Gaur, Vaibhav, Jr.
    HEPATOLOGY, 2021, 74 : 1232A - 1232A
  • [35] Secondary Prophylaxis of hepatic Encephalopathy with oral Lactulose Quod Erat Demonstrandum?
    Gruenhage, F.
    Lammert, F.
    GASTROENTEROLOGE, 2009, 4 (06): : 555 - 556
  • [36] Oral riboflavin versus oral propranolol in migraine prophylaxis: An open label randomized controlled trial
    Nambiar, Natasha J.
    Aiyappa, Cuckoo
    Srinivasa, R.
    NEUROLOGY ASIA, 2011, 16 (03) : 223 - 229
  • [37] Role of lactulose for prophylaxis against hepatic encephalopathy in cirrhotic patients with upper gastrointestinal bleeding: A randomized trial
    Attapon Rattanasupar
    Arunchai Chang
    Keerati Akarapatima
    Thanongsak Chaojin
    Teerha Piratvisuth
    Indian Journal of Gastroenterology, 2021, 40 : 621 - 629
  • [38] Role of lactulose for prophylaxis against hepatic encephalopathy in cirrhotic patients with upper gastrointestinal bleeding: A randomized trial
    Rattanasupar, Attapon
    Chang, Arunchai
    Akarapatima, Keerati
    Chaojin, Thanongsak
    Piratvisuth, Teerha
    INDIAN JOURNAL OF GASTROENTEROLOGY, 2021, 40 (06) : 621 - 629
  • [39] EFFECT OF USING LACTULOSE AND RIFAXIMIN IN COMPARISON WITH LACTULOSE ONLY THERAPY IN TREATEMENT OF HEPATIC ENCEPHALOPATHY: A RANDOMIZED CONTROLLED TRIAL.
    Akbar, Muneeba
    Jabeen, Moqadsa
    Nayyer, Faiqua
    Maryam
    Sardar, Usama
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2018, 5 (05): : 3259 - 3262
  • [40] EFFICACY OF LACTULOSE VS LACTULOSE WITH RIFAXAMIN IN PATIENTS WITH HEPATIC ENCEPHALOPATHY; A RANDOMIZED CONTROL TRIAL
    Ahmed, Bilal
    Javaid, Suman
    Batool, Narjis
    INDO AMERICAN JOURNAL OF PHARMACEUTICAL SCIENCES, 2019, 6 (06): : 12241 - 12244